|
Belova K.Yu., Ershova O.B., Nazarova A.V., Matyakubova Z.A.
Reasons and ways to reduce the severity of the acute phase reaction in the treatment of osteoporosis with intravenous bisphosphonates (literature review)
|
№2 / 2024
|
|
O.G. Filimonova
Features of the management of a patient with postmenopausal osteoporosis and vitamin D deficiency: a clinical case
|
№12 / 2021
|
|
S.S. Apetov, V.V. Apetova
Clinical aspects of the diagnosis and treatment of osteoporosis in postmenopausal women
|
№12 / 2021
|
|
O.A. Nikitinskaya, N.V. Toroptsova
THE USE OF ALENDRONATE GENERICS IN REAL CLINICAL PRACTICE
|
№s3-17 / 2017
|
|
M.E. Telnova, N.A. Petunina
BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS. EFFICACY AND SAFETY OF IBANDRONATE
|
№5 / 2017
|
|
S.S. Rodionova, U.R. Khakimov
RATIONALE FOR USE OF ALFACALCIDOL IN COMBINATION WITH BISPHOSPHONATES IN POSTMENOPAUSAL AND SENILE FORMS OF SYSTEMIC OSTEOPOROSIS
|
№s3-16 / 2016
|
|
A.V. Pashentseva, A.F. Verbovoy, O.V. Kosareva, L.A. Sharonova
MODERN POSSIBILITIES OF OSTEOPOROSIS TREATMENT
|
№5 / 2016
|
|
N.Yu. Karpova, M.A. Rashid, I.V. Pogonchenkova
OSTEOPOROSIS AFTER STROKE: FEATURES OF DEVELOPMENT, DIAGNOSIS AND TREATMENT
|
№19 / 2015
|
|
I.Yu.Golovach
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: HISTORICAL ASPECTS AND MODERN APPROACHES TO PREVENTION AND TREATMENT
|
№s4-15 / 2015
|
|
L.A. Marchenkova
POSTMENOPAUSAL OSTEOPOROSIS AS A MEDICAL-SOCIAL AND ECONOMIC PROBLEM OF THE XXI CENTURY
|
№s4-15 / 2015
|
|
S.N. Ivanov (1), A.Yu. Kochish (1), L.B. Reznik (2), E.V. Sannikova (1)
VIEW OF ORTHOPEDIST-TRAUMATOLOGIST ON THE POSSIBILITY OF USING TERIPARATIDE IN PATIENTS WITH OSTEOPOROTIC BONE FRACTURES
|
№7 / 2015
|
|
A.Yu. Kochish, S.N. Ivanov
CASE OF OSTEONECROSIS OF THE MAXILLA IN PATIENT WITH POSTMENOPAUSAL OSTEOPOROSIS AGAINST THE BACKGROUND OF PROLONGED TREATMENT WITH ANTIRESORPTIVE DRUGS
|
№5 / 2015
|
Русский
